Report From the Drug Bioequivalence Study Panel to the Office of Technology Assessment

Drug Intelligence & Clinical Pharmacy
doi 10.1177/106002807400800801
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Office of Technology Assessment

English

Office of Technology Assessment

Science
MultidisciplinaryPhilosophy of ScienceHistory
1977English

Expert Approaches to the Assessment of Losartan Drugs Bioequivalence

The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
2020English

Phase 2 Cost Quality Management Assessment Report for the Office of Technology Development (EM-50)

1994English

Report From the Catalan Agency for Health Technology Assessment (Cahta)

International Journal of Technology Assessment in Health Care
Health Policy
1999English

From the FDA: Panel Recommends Approval of Drug for ALS

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Drug Treatment and Testing Orders: Final Evaluation Report--Home Office Research Study 212

2000English

From Health Technology Assessment to Health Technology Sustainability

Sustainability
DevelopmentManagementMonitoringEnvironmental ScienceRenewable EnergyEnergy EngineeringLawSustainabilityPlanningPolicyPower Technologythe EnvironmentGeography
2018English

Generic Drug Product Development Bioequivalence Issues

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy